Becton Dickinson plans to spin off its Biosciences and Diagnostic Solutions unit, targeting a fiscal 2026 completion, while updating FY25 revenue guidance.

Copyright © 2025 Bleacher Report, Inc. A Warner Bros. Discovery Company. All Rights Reserved.

BD (NYSE: BDX) announced that its board unanimously authorized management to pursue the separation of its Life Sciences ...

CytoMed Therapeutics Limited (NASDAQ: GDTC) ("CytoMed" or the "Company") today released a letter to shareholders from the Chairman of the Company's Board ...

It’s getting hotter — and more expensive to stay cool — in the island nation. Will it become the first in Southeast Asia to ...

The crowds following the president to Palm Beach in this second term are finding a transformed hub of American wealth and power.

After months of deliberation, and no formal offers from a buyer, Novartis has decided that its generics business Sandoz will be spun out ... health unit to Eli Lilly and a blood diagnostics ...

The Manipur chief minister has finally stepped down. Could he have handled the ethnic strife and bloodshed in the state since ...

Imagine for a moment the tenacious men and women engaged in the economic pursuit of gold—not merely by moving the ...

Haemorrhage: if requiring reoperation, radiological or endoscopic intervention; information on postoperative transfusion of blood products (type and number of units) will also be ... Blood samples ...